The CCK-8 assay revealed that overexpressing OTUD3 increased B-cell lymphoma cell proliferation, whereas knocking down OTUD3 decreased B-cell lymphoma cell proliferation (Figs. 1C, S1G). This evidence concerns the gene OTUD3 and B-cell non-Hodgkin lymphoma.